- Investing Ideas
- Belgian Pharmaceuticals & Biotech Stable Growth Stocks
Belgian Pharmaceuticals & Biotech Stable Growth Stocks
Results
2
0 new
2 companies
UCB
Market Cap: €52.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€274.90
7D
5.3%
1Y
68.2%
argenx
Market Cap: €48.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€783.60
7D
2.3%
1Y
55.9%